Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.75% | -2.25% | -7.89% | -10.29% | -18.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.75% | -2.25% | -7.89% | -10.29% | -18.36% |
| Cost of Revenue | -4.03% | 13.01% | 5.86% | 11.16% | 0.89% |
| Gross Profit | 26.02% | -5.42% | -10.83% | -14.65% | -22.27% |
| SG&A Expenses | 4.23% | 1.48% | -8.09% | -9.20% | -13.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.66% | -7.78% | -8.00% | -3.15% | -5.80% |
| Operating Income | 9.11% | 9.57% | 8.04% | 0.66% | 1.44% |
| Income Before Tax | 6.32% | 6.12% | 20.47% | 8.81% | 13.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.32% | 6.12% | 20.47% | 8.81% | 13.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 26.29% | -47.53% | -49.54% | -42.80% | -36.13% |
| Net Income | 6.80% | 4.96% | 19.77% | 8.03% | 12.97% |
| EBIT | 9.11% | 9.57% | 8.04% | 0.66% | 1.44% |
| EBITDA | 9.33% | 9.91% | 8.39% | 0.55% | 1.62% |
| EPS Basic | 87.47% | 68.94% | 0.15% | -- | -- |
| Normalized Basic EPS | 88.45% | 73.43% | -25.69% | -- | -- |
| EPS Diluted | 87.32% | 68.76% | -0.12% | -- | -- |
| Normalized Diluted EPS | 88.45% | 73.43% | -25.69% | -- | -- |
| Average Basic Shares Outstanding | 1,705.84% | 2,272.27% | 1,987.29% | -- | -- |
| Average Diluted Shares Outstanding | 1,705.84% | 2,272.27% | 1,987.29% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |